Skip to main content

Gastrointestinal Bleeding

  • Chapter
  • 3053 Accesses

Abstract

Gastrointestinal bleeding (GIB) in the critical care environment is a relatively common clinical event. The incidence of GIB is 103/100,000 cases per year in the United Kingdom (UK).1 Of these, 14% occur in patients who are already hospitalized.1 In the United States (US) the incidence of clinically significant GIB from stress-related mucosal disease (SRMD) has been estimated at 1.5%.2 GIB can be the primary reason for admission or can develop as a secondary comorbid factor in relation to the primary illness. Patients with this complication can have an increased length of stay and up to a fourfold rise in mortality.3

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Rockall TA, Logan RFA, Devlin HB et al (1995) Incidence of and mortality from acute upper gastrointestinal hemorrhage in the United Kingdom. BMJ 311:222–226

    Article  PubMed  CAS  Google Scholar 

  2. Cook DJ, Fuller HD, Guyatt GH et al (1994) Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 330:377–381

    Article  PubMed  CAS  Google Scholar 

  3. Cook DJ, Griffith LE, Walter SD et al (2001) The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 5(6):368–375

    Article  PubMed  CAS  Google Scholar 

  4. Jain SK, Bedi APS, Suryavanshi M. Applied Anatomy and Physiology of Stomach and Duodenum. http://www.edu.rcsed.ac.uk, accessed February 29, 2008.

  5. Calam J, Baron JH (2001) ABC of the upper GI tract: pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ 323:980–982

    Article  PubMed  CAS  Google Scholar 

  6. Allen A, Flemstrom G (2005) Gastroduodenal mucus bicarbonate barrier: protection against acid and pepsin. Am J Physiol Cell Physiol 288(1):C1–C19

    PubMed  CAS  Google Scholar 

  7. Ritchie WP Jr (1975) Acute gastric mucosal damage induced by bile salts, acid, and ischemia. Gastroenterology 68(4 Pt 1):699–707

    PubMed  Google Scholar 

  8. Kivilaakso E, Silen W (1979) Pathogenesis of experimental gastric-mucosal injury. N Engl J Med 301(7):364–369

    Article  PubMed  CAS  Google Scholar 

  9. Mutlu GM, Mutlu EA, Factor P (2001) GI complications in patients receiving mechanical ventilation. Chest 119(4):1222–1241

    Article  PubMed  CAS  Google Scholar 

  10. Lev R, Molot MD, McNamara J et al (1971) “Stress” ulcers following war wounds in Vietnam. A morphologic and histochemical study. Lab Invest 25(6):491–502

    PubMed  CAS  Google Scholar 

  11. Hastings PR, Skillman JJ, Bushnell LS et al (1978) Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med 298(19):1041–1045

    Article  PubMed  CAS  Google Scholar 

  12. Fiddian-Green RG, McGough E, Pittenger G et al (1983) Predictive value of intramural pH and other risk factors for massive bleeding from stress ulceration. Gastroenterology 85:613–620

    PubMed  CAS  Google Scholar 

  13. Patrono C, Bachmann F, Baigent C et al (2004) Expert consensus document on the use of antiplatelet agents. Eur Heart J 25(2):166–181

    Article  PubMed  Google Scholar 

  14. Weil J, Colin-Jones D, Langman M et al (1995) Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 310(6983):827–830

    Article  PubMed  CAS  Google Scholar 

  15. Harker LA, Boisell JP, Pilgrim AJ et al (1999) Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. Drug Saf 21(4):325–335

    Article  PubMed  CAS  Google Scholar 

  16. Ng FH, Wong SY, Chang CM et al (2003) High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 18(4):443–449

    Article  PubMed  CAS  Google Scholar 

  17. Ng FH, Wong BC, Wong SY et al (2004) Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk – a single-blind, randomized controlled study. Aliment Pharmacol Ther 19(3):359–365

    Article  PubMed  CAS  Google Scholar 

  18. Liberopoulous EN, Elisaf MS, Tselepis AD et al (2006) Upper gastrointestinal hemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now? Platelets 17(1):1–6

    Article  CAS  Google Scholar 

  19. Grosser T, Fries S, FitzGerald GA (2006) Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116(1):4–15

    Article  PubMed  CAS  Google Scholar 

  20. Henry D, McGettigan P (2007) Selective COX-2 inhibitors: a promise unfulfilled? Gastroenterology 132(2):790–794

    Article  PubMed  CAS  Google Scholar 

  21. Kearney PM, Baigent C, Godwin J et al (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials. BMJ 332(7553):1302–1308

    Article  PubMed  CAS  Google Scholar 

  22. Chan FK, Wong VW, Suen BY et al (2007) Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomized trial. Lancet 369(9573):1621–1626

    Article  PubMed  CAS  Google Scholar 

  23. Chan FK (2002) Helicobacter pylori, NSAIDs and gastrointestinal hemorrhage. Eur J Gastroenterol Hepatol 14(1):1–3

    Article  PubMed  Google Scholar 

  24. Robertson MS, Cade JF, Clancy RL (1999) Helicobacter pylori infection in intensive care: increased prevalence and a new nosocomial infection. Crit Care Med 27(7):1276–1280

    Article  PubMed  CAS  Google Scholar 

  25. van der Voort PH, van der Hulst RW, Zandstra DF et al (2001) Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med 27(1):68–73

    Article  PubMed  Google Scholar 

  26. Halm U, Halm F, Thein D et al (2000) Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med 28(1):110–113

    Article  PubMed  CAS  Google Scholar 

  27. Ong SP, Duggan A (2004) Eradication of Helicobacter pylori in clinical situations. Clin Exp Med 4(1):30–38

    Article  PubMed  CAS  Google Scholar 

  28. Gisbert JP, Abraira V (2006) Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta analysis. Am J Gastroenterol 101(4):848–863

    Article  PubMed  Google Scholar 

  29. Morgner A, Labenz J, Miehlke S (2006) Effective regimens for the treatment of Helicobacter pylori infection. Expert Opin Investig Drugs 15(9):991–994

    Article  Google Scholar 

  30. Kolbel CB, Rippel K, Klar H et al (2000) Esophageal motility disorders in critically ill patients: a 24-hour manometric study. Intensive Care Med 26(10):1421–1427

    Article  PubMed  CAS  Google Scholar 

  31. Castell DO, Murray JA, Tutuian R et al (2004) Review article: the pathophysiology of gastro-esophageal reflux disease – esophageal manifestations. Aliment Pharmacol Ther 20(Suppl 9):14–25

    Article  PubMed  Google Scholar 

  32. Newton M, Burnham WR, Kamm MA (2000) Morbidity, mortality, and risk factors for esophagitis in hospital inpatients. J Clin Gastroenterol 30(3):264–269

    Article  PubMed  CAS  Google Scholar 

  33. Wessinger S, Kaplan M, Choi L et al (2006) Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal hemorrhage: a multicentre retrospective analysis. Aliment Pharmacol Ther 23(7):937–944

    Article  PubMed  CAS  Google Scholar 

  34. Yuan Y, Tsoi K, Hunt RH (2006) Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 119(9):719–727

    Article  PubMed  CAS  Google Scholar 

  35. Luecke T, Pelosi P (2005) Clinical review: positive end-expiratory pressure and cardiac output. Crit Care 9(6):607–621

    Article  PubMed  Google Scholar 

  36. Bosch J, Abraldes JG, Groszmann R (2003) Current management of portal Hypertension. J Hepatol 38(Suppl 1):S54–S68

    Article  PubMed  Google Scholar 

  37. Koklu S, Koksal A, Yolcu OF et al (2004) Isolated splenic vein thrombosis: an unusual cause and review of the literature. Can J Gastroenterol 18(3):173–174

    PubMed  Google Scholar 

  38. Schepis F, Camma C, Niceforo D et al (2001) Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 33(2):333–338

    Article  PubMed  CAS  Google Scholar 

  39. Portal hypertension in cirrhosis: natural history. In: Bosch J, Groszmann R, editors. Portal hypertension. Pathophysiology and treatment. Cambridge, MA: Blackwell; 1994. p. 72–92.

    Google Scholar 

  40. Carbonell N, Pauwels A, Serfaty L et al (2004) Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40(3):652–659

    Article  PubMed  Google Scholar 

  41. de Franchis R, Primignani M (2001) Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 5(3):645–663

    Article  PubMed  Google Scholar 

  42. Ben Ari Z, Cardin F, McCormick AP et al (1999) A predictive model for failure to control bleeding during acute variceal hemorrhage. J Hepatol 31(3):443–450

    Article  PubMed  CAS  Google Scholar 

  43. Moitinho E, Escorsell A, Bandi JC et al (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117(3):626–631

    Article  PubMed  CAS  Google Scholar 

  44. Pique JM (1997) Portal hypertensive gastropathy. Baillieres Clin Gastroenterol 11(2):257–270

    Article  PubMed  CAS  Google Scholar 

  45. Carpinelli L, Primignani M, Preatoni P et al (1997) Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club. Ital J Gastroenterol Hepatol 29(6):533–540

    PubMed  CAS  Google Scholar 

  46. Primignani M, Carpinelli L, Preatoni P et al (2000) Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119(1):181–187

    Article  PubMed  CAS  Google Scholar 

  47. Burak KW, Lee SS, Beck PL (2001) Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 49(6):866–872

    Article  PubMed  CAS  Google Scholar 

  48. Trevino HH, Brady CE 3rd, Schenker S (1996) Portal hypertensive gastropathy. Dig Dis 14(4):258–270

    Article  PubMed  CAS  Google Scholar 

  49. Jabbari M, Cherry R, Lough JO et al (1984) Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 87(5):1165–1170

    PubMed  CAS  Google Scholar 

  50. Payen JL, Cales P (1991) Gastric modifications in cirrhosis. Gastroenterol Clin Biol 15:285–295

    PubMed  CAS  Google Scholar 

  51. Gostout CJ, Viggiano TR, Ahlquist DA et al (1992) The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 15(3):256–263

    Article  PubMed  CAS  Google Scholar 

  52. Villeneuve SL, JP DMP et al (1999) Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 44(5):739–742

    Article  PubMed  Google Scholar 

  53. Schoonbroodt D, Horsmans Y, Hoang P et al (1994) Vascular gastric anomalies, CREST syndrome and primary biliary cirrhosis: efficacy of ethinyl estradiol-norethisterone combination. Gastroenterol Clin Biol 18(6–7):649–651

    PubMed  CAS  Google Scholar 

  54. Henry DA, O’Connell DL (1989) Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal hemorrhage. BMJ 298(6681):1142–1146

    Article  PubMed  CAS  Google Scholar 

  55. Sato T, Yamazaki K, Toyota J et al (2005) Efficacy of argon plasma coagulation for gastric antral vascular ectasia associated with chronic liver disease. Hepatol Res 32(2):121–126

    Article  PubMed  Google Scholar 

  56. Romaozinho JM, Pontes JM, Lerias M et al (2004) Dieulafoy’s lesion: management and long-term outcome. Endoscopy 36(5):416–420

    Article  PubMed  CAS  Google Scholar 

  57. Sone Y, Kumada T, Toyoda H et al (2005) Endoscopic management and follow up of Dieulafoy lesion in the upper gastrointestinal tract. Endoscopy 37(5):449–453

    Article  PubMed  CAS  Google Scholar 

  58. Longstreth GF (1997) Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 92(3):419–424

    PubMed  CAS  Google Scholar 

  59. Peura DA, Lanza FL, Gostout CJ et al (1997) The American College of Gastroenterology Bleeding Registry: preliminary findings. Am J Gastroenterol 92(6):924–928

    PubMed  CAS  Google Scholar 

  60. Vernava AM 3rd, Moore BA, Longo WE et al (1997) Lower gastrointestinal bleeding. Dis Colon Rectum 40(7):846–858

    Article  PubMed  Google Scholar 

  61. Yousfi M, Gostout CJ, Baron TH et al (2004) Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 99(9):1785–1789

    Article  PubMed  Google Scholar 

  62. Hui AJ, Wong RM, Ching JY et al (2004) Risk of colonoscopic polypectomy bleeding with anticoagulants and anti-platelet agents: analysis of 1657 cases. Gastrointest Endosc59(1):44–48

    Article  PubMed  Google Scholar 

  63. Rockall TA, Logan RF, Devlin HB et al (1996) Risk assessment after acute upper gastrointestinal hemorrhage. Gut 38(3):316–321

    Article  PubMed  CAS  Google Scholar 

  64. Camellini L, Merighi A, Pagnini C et al (2004) Comparison of three different risk scoring systems in non-variceal upper gastrointestinal bleeding. Dig Liver Dis 36(4):271–277

    Article  PubMed  CAS  Google Scholar 

  65. Blatchford O, Murray WR, Blatchford M (2000) A risk score to predict need for treatment for upper-gastrointestinal hemorrhage. Lancet 356(9238):1318–1321

    Article  PubMed  CAS  Google Scholar 

  66. Rudolph SJ, Landsverk BK, Freeman ML (2003) Endotracheal intubation for airway protection during endoscopy for severe upper GI hemorrhage. Gastrointest Endosc 57(1):58–61

    Article  PubMed  Google Scholar 

  67. Mandelstam P, Zeppa R (1983) Endotracheal intubation should precede esophagogastric balloon tamponade for control of variceal bleeding. J Clin Gastroenterol 5(6):493–494

    Article  PubMed  CAS  Google Scholar 

  68. Grenvick A, Ayres S, Holbrook P et al (eds) (2000) Textbook of critical care, 4th edn. WB Saunders, Philadelphia, pp 40–45

    Google Scholar 

  69. Kwan I, Bunn F, Roberts I, WHO pre-hospital trauma care steering committee. Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst Rev 2003;(3):CD002245.

    Google Scholar 

  70. Palmer KR, British Society of Gastroenterology Endoscopy Committee. Non variceal upper gastrointestinal hemorrhage: guidelines. Gut 2002;51(Suppl IV):iv1–iv6.

    Google Scholar 

  71. Hebert PC, Wells G, Blajchman MA et al (1999) A multicentre, randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340(6):409–417

    Article  PubMed  CAS  Google Scholar 

  72. Vlavianos P, Mac Mathuna P, Williams R et al (1999) Splanchnic and systemic haemodynamic response to Volume changes in patients with cirrhosis and portal hypertension. Clin Sci (Lond) 96(5):475–481

    Article  CAS  Google Scholar 

  73. Abraldes JG, Dell’Era A, Bosch J (2004) Medical management of variceal bleeding in patients with cirrhosis. Can J Gastroenterol 18(2):109–113

    PubMed  Google Scholar 

  74. Love DG (1999) Management of hemorrhagic events in patients receiving anticoagulant therapy. J Thromb Thrombolysis 7(2):149–152

    Article  PubMed  CAS  Google Scholar 

  75. Baglin T (1998) Management of warfarin overdose. Blood Rev 12(2):91–98

    Article  PubMed  CAS  Google Scholar 

  76. Marti-Carvajal AJ, Salanti G, Marti-Carvajal PI. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases. Cochrane Database Syst Rev 2007;(1):CD004887.

    Google Scholar 

  77. Bosch J, Thabut D, Bendsten F et al (2004) Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 127(4):1123–1130

    Article  PubMed  CAS  Google Scholar 

  78. O’Connell KA, Wood JJ, Wise RP et al (2006) Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 295(3):293–298

    Article  PubMed  Google Scholar 

  79. Hedner U (2007) Recombinant factor VIIa: it’s background, development and clinical use. Curr Opin Hematol 14(3):225–229

    Article  PubMed  CAS  Google Scholar 

  80. Vorder Bruegge WF, Peura DA (1990) Stress-related mucosal damage: review of drug therapy. J Clin Gastroenterol 12(Suppl 2):S35–S40

    Article  PubMed  Google Scholar 

  81. Silen W (1980) The prevention and management of stress ulcers. Hosp Pract 15(3):93–100

    PubMed  CAS  Google Scholar 

  82. Cook DJ, Reeve BK, Guyatt GH et al (1996) Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 275(4):308–314

    Article  PubMed  CAS  Google Scholar 

  83. Modlin IM, Sachs G (1998) Inhibition of the gastric acid pump. In: Modlin IM, Sachs G (eds) Acid related diseases: biology and treatment. Schnetztor-Verlag GmbH D-Konstanz, Konstanz, pp 126–145

    Google Scholar 

  84. Lasky MR, Metzler MH, Phillips JO (1998) A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 44(3):527–533

    Article  PubMed  CAS  Google Scholar 

  85. Phillips JO, Metzler MH, Palmieri MT et al (1996) A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 24(11):1793–1800

    Article  PubMed  CAS  Google Scholar 

  86. Stollman N, Metz DC (2005) Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 20(1):35–45

    Article  PubMed  Google Scholar 

  87. Netzer P, Gaia C, Sandoz M et al (1999) Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol 94(2):351–357

    PubMed  CAS  Google Scholar 

  88. Brett S (2005) Science review: the use of proton pump inhibitors for gastric acid suppression in critical illness. Critical Care 9(1):45–50

    Article  PubMed  Google Scholar 

  89. Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32(3):858–873

    Article  PubMed  Google Scholar 

  90. The Surviving Sepsis Campaign (SSC), an initiative of the European Society of Intensive Care Medicine, the International Sepsis Forum, and the Society of Critical Care Medicine, http://www.survivingsepsis.org, accessed February 29, 2008.

  91. Ostro MJ, Russell JA, Soldin SJ et al (1985) Control of gastric pH with cimetidine: boluses versus primed infusions. Gastroenterology 89(3):532–537

    PubMed  CAS  Google Scholar 

  92. Lau JY, Sung JJ, Lee KK et al (2000) Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343(5):310–316

    Article  PubMed  CAS  Google Scholar 

  93. Lau JY, Leung WK, Wu JC et al (2007) Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356(16):1631–1640

    Article  PubMed  CAS  Google Scholar 

  94. Leontiadis GI, Sharma VK, Howden CW (2007) Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 82(3):286–296

    PubMed  CAS  Google Scholar 

  95. Cooper GS, Chak A, Way LE et al (1999) Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery and length of hospital stay. Gastrointest Endosc 49(2):145–152

    Article  PubMed  CAS  Google Scholar 

  96. Pinkas H, McAllister E, Norman J et al (1995) Prolonged evaluation of epinephrine and normal saline solution injections in an acute ulcer model with a single bleeding artery. Gastrointest Endosc 42(1):51–55

    Article  PubMed  CAS  Google Scholar 

  97. Cook DJ, Gayatt GH, Salena BJ et al (1992) Endoscopic therapy for acute non-variceal upper hemorrhage: a meta analysis. Gastroenterology 102(1):139–148

    PubMed  CAS  Google Scholar 

  98. Chung SS, Lau JY, Sung JJ et al (1997) Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding peptic ulcers. BMJ 314(7090):1307–1311

    Article  PubMed  CAS  Google Scholar 

  99. Marmo R, Rotondano G, Piscopo R et al (2007) Dual therapy versus monotherapy in the endoscopic treatment of high-risk bleeding ulcers: a meta-analysis of controlled trials. Am J Gastroenterol 102(2):279–289

    Article  PubMed  Google Scholar 

  100. Lo CC, Hsu PI, Lo GH et al (2006) Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcers. Gastrointest Endosc 63(6):767–773

    Article  PubMed  Google Scholar 

  101. Havanond C, Havanond P. Argon plasma coagulation therapy for acute non-variceal upper gastrointestinal bleeding. Cochrane Database Syst Rev 2005;(2):CD003791.

    Google Scholar 

  102. Cipolletta L, Bianco MA, Rotondano G et al (2002) Argon plasma coagulation prevents variceal recurrence after band ligation of esophageal varices: preliminary results of a prospective randomized trial. Gastrointest Endosc 56(4):467–471

    Article  PubMed  Google Scholar 

  103. Lau JY, Sung JJ, Lam YH et al (1999) Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 340(10):751–756

    Article  PubMed  CAS  Google Scholar 

  104. Mazzarolo S, Brady P (2007) Small bowel capsule endoscopy: a systematic review. South Med J 100(3):274–280

    Article  PubMed  Google Scholar 

  105. Lefkovitz Z, Cappell MS, Lookstein R et al (2002) Radiologic diagnosis and treatment of intestinal hemorrhage and ischaemia. Med Clin North Am 86(6):1357–1399

    Article  PubMed  Google Scholar 

  106. Whitaker SC, Gregson RH (1993) The role of angiography in the investigation of acute or chronic gastrointestinal hemorrhage. Clin Radiol 47(6):382–387

    Article  PubMed  CAS  Google Scholar 

  107. Nicholson AA, Ettles DF, Hartley JE et al (1998) Transcatheter coil embolotherapy: a safe and effective option for major colonic hemorrhage. Gut 43(1):79–84

    Article  PubMed  CAS  Google Scholar 

  108. Dempsey DT, Burke DR, Reilly RS et al (1990) Angiography in poor-risk patients with massive non-variceal upper gastrointestinal bleeding. Am J Surg 159(3):282–286

    Article  PubMed  CAS  Google Scholar 

  109. Lang EV, Picus D, Marx MV et al (1992) Massive upper gastrointestinal hemorrhage with normal findings on arteriography : value of prophylactic embolization of the left gastric artery. Am J Roentgenol 158(3):547–549

    Article  CAS  Google Scholar 

  110. Schenker MP, Duszak R Jr, Soulen MC et al (2001) Upper gastro intestinal hemorrhage and trans catheter embolotherapy: clinical and technical factors impact in success and survival. J Vasc Interv Radiol 12(11):1263–1271

    Article  PubMed  CAS  Google Scholar 

  111. d’Othee BJ, Surapaneni P, Rabkin D et al (2006) Microcoil embolization for acute lower gastrointestinal bleeding. Cardiovasc Intervent Radiol 29(1):49–58

    Article  PubMed  Google Scholar 

  112. Kuo WT, Lee DE, Saad WE et al (2003) Superselective microcoil embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Intervent Radiol 14(12):1503–1509

    Article  Google Scholar 

  113. Bandi R, Shetty PC, Sharma RP et al (2001) Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Intervent Radiol 12(12):1399–1405

    Article  CAS  Google Scholar 

  114. Lang EK (1992) Transcatheter embolization in management of hemorrhage from duodenal ulcer: long-term results and complications. Radiology 182(3):703–707

    PubMed  CAS  Google Scholar 

  115. Silver A, Bendick P, Wasvary H (2005) Safety and efficacy of superselective angio embolisation in control of lower gastro intestinal hemorrhage. Am J Surg 189(3):361–363

    Article  PubMed  Google Scholar 

  116. Goulis J, Armonis A, Patch D et al (1998) Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 27(5):1207–1212

    Article  PubMed  CAS  Google Scholar 

  117. Bernard B, Cadranel JF, Valla D et al (1995) Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 108(6):1828–1834

    Article  PubMed  CAS  Google Scholar 

  118. Thalheimer U, Triantos CK, Samonakis DN et al (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54(4):556–563

    Article  PubMed  CAS  Google Scholar 

  119. Hou MC, Lin HC, Liu TT et al (2004) Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 39(3):746–753

    Article  PubMed  CAS  Google Scholar 

  120. Soares-Weiser K, Brezis M, Tur-Kaspa R, et al. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002;(2):CD002907.

    Google Scholar 

  121. Ioannou GN, Doust J, Rockey DC (2003) Systematic review: terlipressin in acute esophageal variceal hemorrhage. Aliment Pharmacol Ther 17(1):53–64

    Article  PubMed  CAS  Google Scholar 

  122. Garcia-Pagan JC, Escorsell A, Moitinho E et al (1999) Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension. Semin Liver Dis 19(4):427–438

    Article  PubMed  CAS  Google Scholar 

  123. Ferguson JW, Tripathi D, Hayes PC (2003) Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther 18(3):253–262

    Article  PubMed  CAS  Google Scholar 

  124. Avgerinos A, Nevens F, Raptis S et al (1997) Early administration of somatostatin and efficacy of sclerotherapy in acute esophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial. Lancet 350(9090):1495–1499

    Article  PubMed  CAS  Google Scholar 

  125. Patch D, Sabin CA, Goulis J et al (2002) A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 123(4):1013–1019

    Article  PubMed  CAS  Google Scholar 

  126. Bureau C, Peron JM, Alric L et al (2002) “A La Carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 36(6):1361–1366

    PubMed  Google Scholar 

  127. Helmy A, Hayes PC (2001) Review article: current endoscopic therapeutic options in the management of variceal bleeding. Aliment Pharmacol Ther 15(5):575–594

    Article  PubMed  CAS  Google Scholar 

  128. The Copenhagen Esophageal Varices Sclerotherapy Project (1984) Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med 311(25):1594–1600

    Article  Google Scholar 

  129. D’Amico G, Pietrosi G, Tarantino I et al (2003) Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 124(5):1277–1291

    Article  PubMed  CAS  Google Scholar 

  130. Gross M, Schiemann U, Muhlhofer A et al (2001) Meta-analysis: efficacy of therapeutic regimens in ongoing variceal bleeding. Endoscopy 33(9):737–746

    Article  PubMed  CAS  Google Scholar 

  131. Laine L, Cook D (1995) Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 123(4):280–287

    Article  PubMed  CAS  Google Scholar 

  132. Seewald S, Sriram PV, Naga M et al (2002) Cyanoacrylate glue in gastric variceal bleeding. Endoscopy 34(11):926–932

    Article  PubMed  CAS  Google Scholar 

  133. Bloomfield L (1999) Working knowledge: instant glue. Sci Am 280:104

    Article  Google Scholar 

  134. Palejwala AA, Smart HL, Hughes M (2000) Multiple pulmonary glue emboli following gastric variceal obliteration. Endoscopy 32(1):S1–S2

    Article  PubMed  CAS  Google Scholar 

  135. Roesch W, Rexroth G (1998) Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices. Endoscopy 30(8):S89–S90

    PubMed  CAS  Google Scholar 

  136. Sengstaken RW, Blakemore AH (1950) Balloon tamponage for the control of hemorrhage from esophageal varices. Ann Surg 131(5):781–789

    Article  PubMed  CAS  Google Scholar 

  137. Panes J, Teres J, Bosch J et al (1988) Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 33(4):454–459

    Article  PubMed  CAS  Google Scholar 

  138. Dearden JC, Hellawell GO, Pilling J et al (2004) Does cooling Sengstaken-Blakemore tubes aid insertion? An evidence based approach. Eur J Gastroenterol Hepatol 16(11):1229–1232

    Article  PubMed  Google Scholar 

  139. Lin TC, Bilir BM, Powis ME (2000) Endoscopic placement of Sengstaken-Blakemore tube. J Clin Gastroenterol 31(1):29–32

    Article  PubMed  CAS  Google Scholar 

  140. Lin AC, Hsu YH, Wang TL et al (2006) Placement confirmation of Sengstaken-Blakemore tube by ultrasound. Emerg Med J 23(6):487

    Article  PubMed  Google Scholar 

  141. Chong CF (2005) Esophageal rupture due to Sengstaken-Blakemore tube misplacement. World J Gastroenterol 11(41):6563–6565

    PubMed  Google Scholar 

  142. Teres J, Cecilia A, Bordas JM et al (1978) Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology 75(4):566–569

    PubMed  CAS  Google Scholar 

  143. Boyer TD, Haskal ZJ (2005) American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension. J Vasc Interv Radiol 16(5):615–629

    Article  PubMed  Google Scholar 

  144. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40(4):793–801

    PubMed  Google Scholar 

  145. Rössle M, Siegerstetter V, Huber M et al (1998) The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 18(2):73–89

    PubMed  Google Scholar 

  146. Somberg KA, Riegler JL, LaBerge JM et al (1995) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. Am J Gastroenterol 90(4):549–555

    PubMed  CAS  Google Scholar 

  147. Madoff DC, Wallace MJ, Ahrar K et al (2004) TIPS-related hepatic encephalopathy: management options with novel endovascular techniques. Radiographics 24(1):21–36

    Article  PubMed  Google Scholar 

  148. Green BT, Rockey DC, Portwood G et al (2005) Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: a randomized controlled trial. Am J Gastroenterol 100(11):2395–2402

    Article  PubMed  Google Scholar 

  149. Machicado GA, Jensen DM (2006) Endoscopic diagnosis and treatment of severe lower gastrointestinal bleeding. Indian J Gastroenterol 25(Suppl 1):S43–S51

    PubMed  Google Scholar 

  150. Pfenninger JL (1997) Modern treatments for internal haemorrhoids. BMJ 314(7089):1211–1212

    Article  PubMed  CAS  Google Scholar 

  151. Edelman DA, Sugawa C (2007) Lower gastrointestinal bleeding: a review. Surg Endosc 21(4):514–520

    Article  PubMed  Google Scholar 

  152. Marohn MR, Hanly EJ, McKenna KJ et al (2005) Laparoscopic total abdominal colectomy in the acute setting. J Gastrointest Surg 9(7):881–886

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Thomson, S.J., Cowan, M.L., Morgan, R., Rahman, T.M. (2010). Gastrointestinal Bleeding. In: O’Donnell, J.M., Nácul, F.E. (eds) Surgical Intensive Care Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-77893-8_41

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-77893-8_41

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-77892-1

  • Online ISBN: 978-0-387-77893-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics